{"title":"分枝杆菌噬菌体治疗：克服挑战，释放潜力。","authors":"Christoffel Johannes Opperman, Adrian J Brink","doi":"10.3390/idr17020024","DOIUrl":null,"url":null,"abstract":"<p><p>Bacteriophage (phage) therapy is emerging as a promising alternative to traditional antibiotics for treating drug-resistant mycobacterial infections, including <i>Mycobacterium tuberculosis</i> complex (MTBC) and non-tuberculous mycobacteria (NTM) [...].</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"17 2","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11932251/pdf/","citationCount":"0","resultStr":"{\"title\":\"Phage Therapy for <i>Mycobacteria</i>: Overcoming Challenges, Unleashing Potential.\",\"authors\":\"Christoffel Johannes Opperman, Adrian J Brink\",\"doi\":\"10.3390/idr17020024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Bacteriophage (phage) therapy is emerging as a promising alternative to traditional antibiotics for treating drug-resistant mycobacterial infections, including <i>Mycobacterium tuberculosis</i> complex (MTBC) and non-tuberculous mycobacteria (NTM) [...].</p>\",\"PeriodicalId\":13579,\"journal\":{\"name\":\"Infectious Disease Reports\",\"volume\":\"17 2\",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11932251/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious Disease Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/idr17020024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Disease Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/idr17020024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Phage Therapy for Mycobacteria: Overcoming Challenges, Unleashing Potential.
Bacteriophage (phage) therapy is emerging as a promising alternative to traditional antibiotics for treating drug-resistant mycobacterial infections, including Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM) [...].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
